Dae Young Zang, MD, PhD
Hallym University Medical Center
7
7
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Michel Kahaleh, MD
Weill Medical College of Cornell University
Shared therapeutic areas:
Jean-Philippe Aussel
Sanofi
Shared therapeutic areas:
Worked with same sponsors:
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Tim F Greten, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Raffit Hassan, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
David S Schrump, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Shivaani Kummar, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Docetaxel and S-1 for Advanced Esophageal Cancer
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer
All 7 trials loaded